192 related articles for article (PubMed ID: 23865846)
1. Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains.
Ghosh C; Hossain M; Puvenna V; Martinez-Gonzalez J; Alexopolous A; Janigro D; Marchi N
Epilepsia; 2013 Sep; 54(9):1562-70. PubMed ID: 23865846
[TBL] [Abstract][Full Text] [Related]
2. Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow.
Ghosh C; Gonzalez-Martinez J; Hossain M; Cucullo L; Fazio V; Janigro D; Marchi N
Epilepsia; 2010 Aug; 51(8):1408-17. PubMed ID: 20074231
[TBL] [Abstract][Full Text] [Related]
3. Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood-brain barrier model.
Ghosh C; Hossain M; Mishra S; Khan S; Gonzalez-Martinez J; Marchi N; Janigro D; Bingaman W; Najm I
Epilepsia; 2018 Nov; 59(11):2049-2060. PubMed ID: 30264400
[TBL] [Abstract][Full Text] [Related]
4. Cellular localization and functional significance of CYP3A4 in the human epileptic brain.
Ghosh C; Marchi N; Desai NK; Puvenna V; Hossain M; Gonzalez-Martinez J; Alexopoulos AV; Janigro D
Epilepsia; 2011 Mar; 52(3):562-71. PubMed ID: 21294720
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells.
Ghosh C; Hossain M; Solanki J; Najm IM; Marchi N; Janigro D
Epilepsia; 2017 Apr; 58(4):576-585. PubMed ID: 28199000
[TBL] [Abstract][Full Text] [Related]
6. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
Potschka H; Fedrowitz M; Löscher W
Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
[TBL] [Abstract][Full Text] [Related]
7. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
8. Neurovascular Drug Biotransformation Machinery in Focal Human Epilepsies: Brain CYP3A4 Correlates with Seizure Frequency and Antiepileptic Drug Therapy.
Williams S; Hossain M; Ferguson L; Busch RM; Marchi N; Gonzalez-Martinez J; Perucca E; Najm IM; Ghosh C
Mol Neurobiol; 2019 Dec; 56(12):8392-8407. PubMed ID: 31243719
[TBL] [Abstract][Full Text] [Related]
9. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
Gulcebi MI; Ozkaynakcı A; Goren MZ; Aker RG; Ozkara C; Onat FY
Epilepsy Res; 2011 Jun; 95(1-2):1-8. PubMed ID: 21601426
[TBL] [Abstract][Full Text] [Related]
10. Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients.
Petrenaite V; Öhman I; Jantzen FPT; Ekström L
Epilepsy Res; 2022 May; 182():106897. PubMed ID: 35303539
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China.
Chang Y; Yang LY; Zhang MC; Liu SY
Eur J Clin Pharmacol; 2014 Aug; 70(8):941-6. PubMed ID: 24820767
[TBL] [Abstract][Full Text] [Related]
12. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
[TBL] [Abstract][Full Text] [Related]
13. Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children.
Du Z; Jiao Y; Shi L
Med Sci Monit; 2016 Oct; 22():4107-4113. PubMed ID: 27795544
[TBL] [Abstract][Full Text] [Related]
14. A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.
Ghosh C; Marchi N; Hossain M; Rasmussen P; Alexopoulos AV; Gonzalez-Martinez J; Yang H; Janigro D
Neurobiol Dis; 2012 Jun; 46(3):692-700. PubMed ID: 22426401
[TBL] [Abstract][Full Text] [Related]
15. Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term.
Reimers A; Østby L; Stuen I; Sundby E
Eur J Drug Metab Pharmacokinet; 2011 Jan; 35(3-4):79-82. PubMed ID: 21302032
[TBL] [Abstract][Full Text] [Related]
16. Expression and Functional Relevance of Death-Associated Protein Kinase in Human Drug-Resistant Epileptic Brain: Focusing on the Neurovascular Interface.
Williams S; Hossain M; Mishra S; Gonzalez-Martinez J; Najm I; Ghosh C
Mol Neurobiol; 2019 Jul; 56(7):4904-4915. PubMed ID: 30414085
[TBL] [Abstract][Full Text] [Related]
17. Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy.
Božina N; Sporiš IŠ; Domjanović IK; Ganoci L; Šimičević L; Lovrić M; Romić ZČ; Gadže ŽP; Trkulja V
Eur J Clin Pharmacol; 2023 Aug; 79(8):1117-1129. PubMed ID: 37340142
[TBL] [Abstract][Full Text] [Related]
18. Influence of UGT2B7, UGT1A4 and ABCG2 Polymorphisms on the Pharmacokinetics and Therapeutic Efficacy of Lamotrigine in Patients with Epilepsy.
Yang J; Wang J; Ning L; Wu C; Liu Y; Xia J; Guan Y; Liu Q; Zheng J
Eur J Drug Metab Pharmacokinet; 2024 Jul; 49(4):437-447. PubMed ID: 38709450
[TBL] [Abstract][Full Text] [Related]
19. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy.
Chen H; Yang K; Choi S; Fischer JH; Jeong H
Drug Metab Dispos; 2009 Sep; 37(9):1841-7. PubMed ID: 19546240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
